How Long Does Ecstasy Stay in Your System?

Ecstasy stays in your system for about 40 hours, and drug tests detect it considerably longer. Urine testing detects MDMA and its metabolites for 2 to 5 days.

Blood testing detects the drug for 1 to 3 days and saliva for 1 to 2 days. Hair follicle testing reaches back up to 90 days.

Effects resolve long before the drug does. A high lasting 3 to 6 hours leaves active metabolites circulating for days afterward.

Key Takeaways

• MDMA carries an elimination half-life of approximately 8 hours and requires roughly 40 hours, or five half-lives, to reach over 95% clearance (Figurasin et al., 2024).
• Urine detects ecstasy for 2 to 5 days, blood for 1 to 3 days, saliva for 1 to 2 days, and hair for up to 90 days.
• MDMA inhibits CYP2D6, the liver enzyme that breaks it down. Farré and colleagues measured a 77% rise in total drug exposure on a second dose given 24 hours after the first.
• Basic 5-panel screens produce false negatives for MDMA. Most 12-panel urine tests include a dedicated MDMA target.
• MDMA remains a Schedule I controlled substance with no FDA-approved medical use as of August 2026.

Ecstasy Detection Windows on Each Drug Test

MDMA and its metabolites remain detectable for 2 to 5 days in urine, 1 to 3 days in blood, 1 to 2 days in saliva, and up to 90 days in hair. Ranges assume a typical recreational dose in an adult with normal liver and kidney function.

Test type	Detection window	Clinical notes
Urine	2 to 5 days	Most common matrix; repeated dosing pushes toward the upper end
Blood	1 to 3 days	Used in emergency medicine and forensic casework, rarely by employers
Saliva	1 to 2 days	Detectable within roughly 15 minutes of ingestion
Hair follicle	Up to 90 days	Reflects a standard 1.5-inch sample lookback

The sequence below tracks a single oral dose from ingestion through the close of each window.

1. 20 to 60 minutes: Absorption completes and effects begin.
2. 2 hours: Plasma MDMA reaches peak concentration.
3. 3 to 6 hours: Subjective effects resolve while the drug remains in circulation.
4. 40 hours: Five half-lives elapse and clearance exceeds 95%.
5. 2 to 5 days: Urine assays continue detecting MDMA and its metabolite MDA.
6. Up to 90 days: Hair shaft analysis recovers deposited metabolite.

How long does ecstasy stay in urine?

Urine detects ecstasy for 2 to 5 days after use and serves as the standard matrix for workplace and clinical screening. MDMA appears in urine within 1 to 2 hours of ingestion and concentrations peak during the first 24 hours.

A single moderate dose commonly falls below cutoff thresholds by day three. Repeated dosing across one night regularly extends detection to the full five days.

How long does MDMA stay in blood?

Blood detects MDMA for 1 to 3 days. The window reflects the 8 hour half-life plus the persistence of MDA, an active metabolite with a comparable elimination profile.

Blood draws appear in emergency medicine, impaired driving investigation, and forensic casework. Employers almost never order them.

How long does molly stay in saliva?

Saliva detects MDMA for 1 to 2 days, and the drug appears in oral fluid within roughly 15 minutes of ingestion. Collection is simple and directly observable.

That combination makes saliva testing practical for roadside and for-cause workplace screening. The tradeoff is a narrower window than urine provides.

How long does ecstasy stay in hair?

Hair follicle testing detects MDMA for up to 90 days. Metabolites incorporate into the hair shaft from the bloodstream as new hair grows.

Hair testing cannot establish recent use. A positive result indicates exposure somewhere across the tested growth period rather than within the last several days.

How does the body break down and clear MDMA?

The liver metabolizes MDMA primarily through the CYP2D6 enzyme, and the kidneys excrete the resulting metabolites. The elimination half-life measures approximately 8 to 9 hours, and five half-lives produce the roughly 40 hour figure for near-complete clearance.

Rafael de la Torre and the Barcelona pharmacology group established the metabolic pathway that defines MDMA's behavior. CYP2D6 converts MDMA to HHMA, which catechol-O-methyltransferase then converts to HMMA, while a minor pathway produces the active metabolite MDA.

One feature of that pathway carries direct safety weight. MDMA acts as a mechanism-based inhibitor of CYP2D6, meaning the drug disables the enzyme responsible for removing it, which produces nonlinear kinetics rather than proportional dose response.

Farré and colleagues demonstrated the consequence by administering two 100 mg doses 24 hours apart. Total drug exposure rose 77% and peak concentration rose 29% on the second dose, increases larger than simple accumulation accounts for.

The enzyme stays suppressed for days afterward. O'Mathúna and colleagues measured CYP2D6 recovery over 10 days with a recovery half-life of 46.6 hours, and 67% of their subjects registered as phenotypic poor metabolizers after one dose.

The two mirror-image forms of MDMA clear at different rates. S-MDMA undergoes faster metabolism and shorter elimination, while R-MDMA persists longer with a reported half-life of 11 to 14 hours.

What does MDMA show up as on a drug test?

MDMA registers as MDMA on panels configured to detect it and frequently produces a false negative on panels that are not. Most 12-panel urine tests carry a dedicated MDMA or ecstasy target, which detects molly reliably.

Basic 5-panel screens perform poorly here. StatPearls lists MDMA alongside synthetic cathinones among the substances known to produce false negatives on amphetamine immunoassays, which means a clean 5-panel result carries little information about MDMA use.

Amphetamine immunoassays also generate false positives from unrelated compounds including pseudoephedrine, bupropion, trazodone, and amantadine. Laboratories therefore confirm every presumptive result using gas chromatography or liquid chromatography mass spectrometry before reporting.

What affects how long ecstasy stays in the body?

Dose and redosing dominate the variation in MDMA clearance, amplified by the drug's nonlinear kinetics. Hepatic function, renal function, and CYP2D6 activity account for most of the remainder. No supplement, sports drink, or commercial detox product accelerates elimination. Excessive water intake is specifically dangerous with MDMA, because the drug raises arginine vasopressin and promotes fluid retention, and the combination produces life-threatening hyponatremia.

Variables that lengthen or shorten MDMA detection windows:

• Dose and redosing: The dominant factor, magnified because each additional dose further inhibits the enzyme clearing the previous one.
• Frequency of use: Repeated use across consecutive days accumulates metabolites faster than the kidneys clear them.
• CYP2D6 activity: Genetic variation makes some people markedly slower metabolizers before any drug is taken.
• Liver and kidney function: Impairment in either organ measurably extends clearance.
• Concurrent medications: SSRIs such as fluoxetine and paroxetine inhibit CYP2D6 and slow MDMA elimination while raising serotonin syndrome risk.
• Other substances: Alcohol and stimulants compete for the same hepatic pathways, and combining MDMA with LSD, a pattern called candy flipping, produces two separate metabolite profiles.
• Hydration and urine concentration: These shift measured urine levels without changing actual clearance.

How long does the molly comedown last?

The molly comedown lasts 1 to 3 days, and heavier use extends low mood toward a week. MDMA releases stored serotonin in bulk, and the crash reflects depletion of those stores rather than a withdrawal syndrome.

Comedown symptoms include depressed mood, anxiety, irritability, fatigue, poor concentration, and disrupted sleep. Appetite commonly stays suppressed for a day or two after the drug clears.

Severity scales with dose and frequency. People who redose repeatedly across a single night report markedly worse and longer aftereffects, and persistent low mood between uses warrants assessment for treatment for depression and addiction.

"The comedown after MDMA can look identical to a major depressive episode, and clients are often frightened by how flat and joyless they feel. What we're really treating is serotonin depletion, not a psychiatric illness, but we still monitor closely because the two can be hard to tell apart in the first few days."

— Pam DeHart, MA, LPC, LAC, ADC, Clinical Supervisor, South Carolina Addiction Treatment

Internal outcomes data at South Carolina Addiction Treatment from January 2025 to April 2026 show a 49% average decrease in depression among clients who complete treatment, and 82% of clients who begin treatment complete it.

How long do the effects of ecstasy last?

Ecstasy effects begin 20 to 60 minutes after ingestion, peak near 2 hours, and last 3 to 6 hours. Redosing partway through extends the experience to 5 to 8 hours while sharply increasing total drug exposure.

Physiological effects outlast the euphoria. Elevated heart rate, raised body temperature, bruxism, jaw clenching, and suppressed appetite persist past the subjective peak and into the following hours.

Hyperthermia represents the most acute danger, particularly at crowded events involving sustained physical activity. MDMA impairs thermoregulation, and hyperthermia and hyponatremia are the two most frequently reported causes of MDMA-related death.

Signs that require emergency medical care immediately:

1. Core temperature above 105 degrees Fahrenheit or hot dry skin.
2. Seizure activity of any duration.
3. Chest pain, severe tachycardia, or irregular heartbeat.
4. Confusion, severe headache, or vomiting after heavy fluid intake, which suggests hyponatremia.
5. Muscle rigidity with agitation and fever, which suggests serotonin syndrome.

Are ecstasy, MDMA, and molly the same drug?

Ecstasy, MDMA, and molly all name the same compound, 3,4-methylenedioxymethamphetamine. The three terms describe presentation and marketing rather than distinct chemicals. Ecstasy traditionally refers to pressed tablets and molly to crystalline powder or capsules.

The purity claim attached to molly rarely holds. Laboratory analysis of seized material routinely identifies synthetic cathinones, methamphetamine, MDEA, ketamine, caffeine, or no MDMA at all.

Adulteration changes detection directly. A tablet containing methamphetamine rather than MDMA produces a positive amphetamine result on a standard panel and follows a different clearance timeline entirely.

What is the drug schedule for ecstasy?

MDMA is a Schedule I controlled substance under the U.S. Controlled Substances Act, placed there in 1985. Schedule I designates compounds with high abuse potential and no federally accepted medical use, alongside heroin and LSD.

Clinical research proceeds under Investigational New Drug status and DEA research registration. That research pathway does not alter the legal schedule, and possession carries federal criminal penalties regardless of quantity.

MDMA-assisted therapy for PTSD has not received approval. The FDA issued a Complete Response Letter in August 2024 declining the application and requesting an additional Phase 3 trial, the sponsor accepted that requirement, and no resubmission date exists as of August 2026.

Getting Help With Ecstasy Addiction

MDMA alone produces no withdrawal syndrome requiring detoxification, so medical supervision becomes necessary when MDMA use accompanies alcohol, benzodiazepine, or opioid dependence. South Carolina Addiction Treatment holds licenses for both detox and residential care at its 16-bed CARF-accredited facility in Simpsonville.

Licensed nursing staff cover the campus 24 hours a day, which matters for a drug whose two most frequent causes of death are hyperthermia and hyponatremia. Registered nurses and licensed practical nurses conduct the nursing assessment on arrival, and a psychiatric provider completes the history and physical under Medical Director Gergana Dimitrova, MD.

Medical detox

The medical detox program provides round-the-clock monitoring for clients withdrawing from alcohol, benzodiazepines, or opioids. Ecstasy use rarely arrives alone, and the substance driving the physical withdrawal determines the detox protocol rather than the MDMA itself.

Residential Treatment

The inpatient rehab program addresses the depressive and anxious symptoms that follow serotonin depletion, using cognitive behavioral therapy and dialectical behavior therapy across a minimum of three groups daily. The psychiatric evaluation completed in the first 24 hours distinguishes a comedown from an underlying mood disorder, which changes the treatment plan entirely.

Frequently Asked Questions

Does redosing extend how long ecstasy shows up on a drug test?

Redosing extends every detection window, because MDMA inhibits the enzyme that clears it. Farré and colleagues measured a 77% rise in total drug exposure when a second 100 mg dose followed 24 hours after the first, a larger increase than simple accumulation produces.

Can drinking water flush MDMA out of the body faster?

Water does not accelerate MDMA clearance and carries specific danger with this drug. MDMA raises arginine vasopressin, which causes fluid retention. Combined with heavy water intake, that produces hyponatremia, cerebral edema, seizures, and documented deaths.

Will ecstasy show up on a 5-panel drug test?

A basic 5-panel screen frequently misses MDMA. StatPearls lists MDMA among the substances that produce false negatives on amphetamine immunoassays. Most 12-panel urine tests carry a dedicated MDMA target, and laboratories confirm any presumptive result with chromatography.

How long does it take to feel normal after taking molly?

Mood, sleep, and concentration return to baseline within 1 to 3 days for most people. Heavier or repeated dosing extends low mood toward a week. Serotonin depletion drives the delay, because the neuron requires days to rebuild the stores MDMA released.

Do antidepressants change how the body clears MDMA?

SSRIs including fluoxetine and paroxetine inhibit CYP2D6 and slow MDMA elimination. Combining serotonergic antidepressants with MDMA also raises the risk of serotonin syndrome, a medical emergency producing hyperthermia, muscle rigidity, and altered mental status.

References

1. Figurasin, R., Lee, V. R., & Maguire, N. J. (2024). 3,4-Methylenedioxymethamphetamine (MDMA) toxicity. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538482/
2. de la Torre, R., Farré, M., Roset, P. N., Pizarro, N., Abanades, S., Segura, M., Segura, J., & Camí, J. (2004). Human pharmacology of MDMA: Pharmacokinetics, metabolism, and disposition. Therapeutic Drug Monitoring, 26(2), 137–144. https://pubmed.ncbi.nlm.nih.gov/15228154/
3. de la Torre, R., Farré, M., Ortuño, J., Mas, M., Brenneisen, R., Roset, P. N., Segura, J., & Camí, J. (2000). Non-linear pharmacokinetics of MDMA (ecstasy) in humans. British Journal of Clinical Pharmacology, 49(2), 104–109.
4. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
5. Drug Enforcement Administration. (n.d.). Ecstasy or MDMA (also known as molly) drug fact sheet. U.S. Department of Justice. https://www.dea.gov/factsheets/ecstasy-or-mdma-also-known-molly
6. U.S. Food and Drug Administration. (2024). Complete response letter, NDA 215455 (midomafetamine capsules). U.S. Department of Health and Human Services.